2,5-Dioxopyrrolidin-1-yl docosanoate, 95%, 25g

Methyl 2-amino-5-(trifluoromethyl)nicotinate, 98+%, 1g

7-Methylenebicyclo[3.3.1]nonan-3-one, 95.0%, 1g

5-ethyl-1H-1,2,4-triazole-3-thiol, 100mg

4-AMINO-2-CYANOBENZOIC ACID, 95.0%, 5g

Antimonio in polvere, minimo 99,5%, <100 mesh, 100 g, confezione in plastica.

5-BROMO-N-(2-METHYLPYRIDIN-4-YL)THIOPHENE-2-CARBOXAMIDE, 95.0%, 100mg

Dimethyl sulfoxide, 99.0%, 50ml

(3-Bromo-5-chlorophenyl)methanol, 97%, 25g

6-Hydroxy-N,2-dimethylbenzofuran-3-carboxamide, 97%, 5g

tert-Butyl 5-oxa-2,8-diazaspiro[3.5]nonane-8-carboxylate hydrochloride, 98%, 1g

4-(1,3,4-Oxadiazol-2-yl)benzaldehyde, 97%, 100mg

(R)-Methyl morpholine-2-carboxylate hydrochloride, 95.0%, 250mg